HEADER NUCLEAR PROTEIN 16-SEP-19 6UCH TITLE SMARCB1 NUCLEOSOME-INTERACTING C-TERMINAL ALPHA HELIX COMPND MOL_ID: 1; COMPND 2 MOLECULE: SWI/SNF-RELATED MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR COMPND 3 OF CHROMATIN SUBFAMILY B MEMBER 1; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: BRG1-ASSOCIATED FACTOR 47,BAF47,INTEGRASE INTERACTOR 1 COMPND 6 PROTEIN,SNF5 HOMOLOG,HSNF5; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SMARCB1, BAF47, INI1, SNF5L1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS MSWI-SNF COMPLEX, BAF COMPLEX, CHROMATIN REMODELING, SMARCB1, BAF47, KEYWDS 2 POSITIVE CHARGE CLUSTER, ARGININE CLUSTER, NUCLEOSOME BINDING, ALPHA KEYWDS 3 HELIX, NUCLEAR PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR A.M.VALENCIA,Z.Y.J.SUN,H.S.SEO,H.S.VANGOS,Z.C.YEOH,N.MASHTALIR,S.DHE- AUTHOR 2 PAGANON,C.KADOCH REVDAT 4 01-MAY-24 6UCH 1 REMARK REVDAT 3 11-DEC-19 6UCH 1 JRNL REVDAT 2 04-DEC-19 6UCH 1 JRNL REVDAT 1 27-NOV-19 6UCH 0 JRNL AUTH A.M.VALENCIA,C.K.COLLINGS,H.T.DAO,R.ST PIERRE,Y.C.CHENG, JRNL AUTH 2 J.HUANG,Z.Y.SUN,H.S.SEO,N.MASHTALIR,D.E.COMSTOCK, JRNL AUTH 3 O.BOLONDURO,N.E.VANGOS,Z.C.YEOH,M.K.DORNON,C.HERMAWAN, JRNL AUTH 4 L.BARRETT,S.DHE-PAGANON,C.J.WOOLF,T.W.MUIR,C.KADOCH JRNL TITL RECURRENT SMARCB1 MUTATIONS REVEAL A NUCLEOSOME ACIDIC PATCH JRNL TITL 2 INTERACTION SITE THAT POTENTIATES MSWI/SNF COMPLEX CHROMATIN JRNL TITL 3 REMODELING. JRNL REF CELL V. 179 1342 2019 JRNL REFN ISSN 1097-4172 JRNL PMID 31759698 JRNL DOI 10.1016/J.CELL.2019.10.044 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6UCH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-SEP-19. REMARK 100 THE DEPOSITION ID IS D_1000244044. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 288 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 150 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 300 UM [U-100% 13C; U-100% 15N] REMARK 210 SMARCB1CC, 137 MM NACL, 2.7 MM REMARK 210 POTASSIUM CHLORIDE, 10 MM REMARK 210 NA2HPO4, 1.8 MM KH2PO4, 90% H2O/ REMARK 210 10% D2O; 230 UM SMARCB1CC, 137 REMARK 210 MM NACL, 2.7 MM POTASSIUM REMARK 210 CHLORIDE, 10 MM NA2HPO4, 1.8 MM REMARK 210 KH2PO4, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCA; 3D HNCACB; 3D HNCO; 3D REMARK 210 HN(CO)CA; 3D HN(CA)CO; 3D C(CO) REMARK 210 NH; 3D H(CCO)NH; 3D 1H-15N NOESY; REMARK 210 2D NOESY; 2D TOCSY; 2D 1H-15N REMARK 210 HSQC; 2D 1H-13C HSQC ALIPHATIC; REMARK 210 2D 1H-13C HSQC AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : DD2 REMARK 210 SPECTROMETER MANUFACTURER : AGILENT REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMR, NMRPIPE, HMSIST, CARA, REMARK 210 TALOS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 346 -172.84 -47.66 REMARK 500 1 MET A 350 90.75 -28.24 REMARK 500 1 LEU A 352 38.06 -154.81 REMARK 500 1 LEU A 353 24.60 -168.44 REMARK 500 1 GLU A 354 59.41 -110.34 REMARK 500 1 THR A 355 128.06 -32.87 REMARK 500 1 LEU A 356 -161.68 -109.91 REMARK 500 1 THR A 357 -167.93 -125.16 REMARK 500 1 ALA A 379 78.02 178.62 REMARK 500 1 ASN A 380 110.78 177.53 REMARK 500 1 ALA A 384 148.89 163.66 REMARK 500 2 MET A 350 73.79 -117.69 REMARK 500 2 PRO A 351 -165.97 -47.78 REMARK 500 2 GLU A 354 -136.16 -103.98 REMARK 500 2 LEU A 356 -163.60 -115.12 REMARK 500 2 THR A 357 -169.11 -106.48 REMARK 500 2 LEU A 378 111.87 174.32 REMARK 500 2 ALA A 379 -141.00 -123.76 REMARK 500 2 ASN A 380 -14.48 169.72 REMARK 500 2 ALA A 382 90.59 51.55 REMARK 500 2 PRO A 383 -173.58 -47.82 REMARK 500 2 ALA A 384 82.91 27.05 REMARK 500 3 LEU A 347 131.83 59.04 REMARK 500 3 SER A 349 -139.56 -164.82 REMARK 500 3 LEU A 352 74.53 -114.19 REMARK 500 3 LEU A 353 125.78 173.28 REMARK 500 3 GLU A 354 115.47 54.01 REMARK 500 3 THR A 355 -177.31 -45.96 REMARK 500 3 LEU A 356 -160.79 -100.68 REMARK 500 3 THR A 357 -165.13 -109.03 REMARK 500 3 LEU A 378 39.29 -97.29 REMARK 500 3 ALA A 379 -98.96 -58.76 REMARK 500 3 ASN A 380 -97.63 -66.92 REMARK 500 3 THR A 381 66.08 38.86 REMARK 500 3 ALA A 382 101.67 84.81 REMARK 500 4 PRO A 346 -19.71 -47.65 REMARK 500 4 MET A 350 -61.22 -168.94 REMARK 500 4 LEU A 352 69.92 -106.37 REMARK 500 4 LEU A 356 -161.71 -109.56 REMARK 500 4 THR A 357 -167.78 -126.12 REMARK 500 4 ALA A 379 -100.77 -106.47 REMARK 500 4 ASN A 380 123.51 73.14 REMARK 500 4 THR A 381 121.16 -175.53 REMARK 500 4 ALA A 382 89.52 59.89 REMARK 500 5 PRO A 346 -83.75 -72.77 REMARK 500 5 LEU A 347 81.41 -159.90 REMARK 500 5 SER A 349 45.32 79.71 REMARK 500 5 MET A 350 69.84 34.95 REMARK 500 5 PRO A 351 -164.66 -47.59 REMARK 500 5 LEU A 352 71.28 29.82 REMARK 500 REMARK 500 THIS ENTRY HAS 107 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30672 RELATED DB: BMRB REMARK 900 SMARCB1 NUCLEOSOME-INTERACTING C-TERMINAL ALPHA HELIX DBREF 6UCH A 351 385 UNP Q12824 SNF5_HUMAN 351 385 SEQADV 6UCH GLY A 345 UNP Q12824 EXPRESSION TAG SEQADV 6UCH PRO A 346 UNP Q12824 EXPRESSION TAG SEQADV 6UCH LEU A 347 UNP Q12824 EXPRESSION TAG SEQADV 6UCH GLY A 348 UNP Q12824 EXPRESSION TAG SEQADV 6UCH SER A 349 UNP Q12824 EXPRESSION TAG SEQADV 6UCH MET A 350 UNP Q12824 EXPRESSION TAG SEQRES 1 A 41 GLY PRO LEU GLY SER MET PRO LEU LEU GLU THR LEU THR SEQRES 2 A 41 ASP ALA GLU MET GLU LYS LYS ILE ARG ASP GLN ASP ARG SEQRES 3 A 41 ASN THR ARG ARG MET ARG ARG LEU ALA ASN THR ALA PRO SEQRES 4 A 41 ALA TRP HELIX 1 AA1 THR A 357 LEU A 378 1 22 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1